Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Hamilton Robotics Partners with Coastal Genomics

Published: Tuesday, January 21, 2014
Last Updated: Monday, January 20, 2014
Bookmark and Share
New, automated workstation enables agarose gel size selection in just two hours.

At the annual Society for Laboratory Automation and Screening (SLAS) meeting Hamilton Robotics has announced a partnership with Coastal Genomics to launch the new Microlab® NIMBUS® Select workstation with Ranger Technology.

The new automated workstation provides a faster and more economical automated solution to agarose gel selection of DNA fragments, generating high-quality material for downstream use in next-generation sequencing (NGS), cloning and gene synthesis applications.

The partnership with Coastal Genomics has enabled Hamilton Robotics to access an innovative technology, validated at one of the world’s largest genome centers, and expands the applications available on the NIMBUS workstation.

Ranger Technology targets DNA and isolates fractions with high sensitivity and accuracy; recovery yields typically exceed 80% of the intrinsic content in the targeted range.

“The workstation offers high quality, gel-based size selection at a scale that meets the demands of any lab," explained Matthew Nesbitt, President of Coastal Genomics. "However, it also generates analytics that can be used to assess the input sample both before and after the size selection event. This feature could consolidate multiple processes into a single run with Ranger Technology.”

Agarose gel size selection is a key component in sample preparation and quality control used throughout the life sciences. By automating pipetting steps, the NIMBUS Select Workstation with Ranger Technology eliminates manual gel preparation, which is considered one of the most labor-intensive and error-prone steps. In an average two-hour run, the workstation can accurately process up to 96 samples and then place the fragments in destination labware.

Coastal Genomics’ technology has been successfully validated to size select thousands of DNA samples processed by a major scientific research center in British Columbia. The center has effectively eliminated manual agarose gel size selection for multiple sequencing protocols for sample types involving microRNA, genomic DNA and formalin-fixed paraffin-embedded (FFPE) tissue.

The NIMBUS Select Workstation with Ranger Technology offers numerous performance and quality control benefits over manual processing and other automated platforms. As an open automation platform, the workstation can be used for many applications and works with multiple NGS instrument manufacturers. The NIMBUS instrument's 96-channel CO-RE head provides an unmatched pipetting dynamic range of 1 µL to 1,000 µL.

Because sample processing does not always come in precise 96-sample batches, the workstation has the built-in flexibility to automate workflows from one to 96 samples at a time. Quality control metrics, including individual gel images and electropherogram traces, are captured for each sample.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Researchers Develop Software That Could Facilitate Drug Development
AptaTRACE can identify aptamers, potentially speed drug advancement.
Gene Therapy for Metabolic Liver Diseases
Researchers have tested gene therapy in pigs from hereditary tyrosinemia type 1, with corrected liver cells being transplanted into the diseased liver.
Zika Vaccine Candidates Show Promise
Two experimental vaccines have shown promise against a major viral strain responsible for the Brazilian Zika outbreak.
New Medication Shows Promise Against Liver Fibrosis in Animal Studies
Liver fibrosis is a gradual scarring of the liver that puts people at risk for progressive liver disease and liver failure.
Raw Eggs Deemed Safe to Eat
A report published today by the Advisory Committee on the Microbiological Safety of Food (ACMSF) into egg safety has shown a major reduction in the risk from salmonella in UK eggs.
Monitoring TTX Toxin in Shellfish
In a number of small studies, mussels and oysters from the eastern and northern part of the Oosterschelde in Holland were found to contain tetrodotoxin (TTX).
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!